高盛中投达成价值高达50亿美元的交易

编辑:给力英语新闻 更新:2017年11月16日 作者:纽约时报中文网(By ANA SWANSON and KEITH BRADSHER)

上周,高盛首席执行官劳尔德·C·贝兰克梵(Lloyd C. Blankfein)在特朗普会晤习近平期间。
上周,高盛首席执行官劳尔德·C·贝兰克梵(Lloyd C. Blankfein)在特朗普会晤习近平期间。

华盛顿——特朗普政府承诺对中国为了提升与美国竞争的实力而购买美国技术知识的行为,采取更加强硬的立场。

因此在特朗普上周访问北京期间,几乎没人料到华尔街的一家大银行会宣布自己同中国政府的一个附属机构合作,以便在美国达成价值高达50亿美元的交易。

高盛(Goldman Sachs)与中国的主权财富基金中国投资有限责任公司(简称中投公司)的这项协议,说明了华盛顿在中国的贸易和投资做法上的深刻分歧,以及对流入美国的中国资金进行监管的复杂性。

周三,在特朗普政府的部分官员称赞该协议对美国企业有利一周后,国会的一个委员会建议立法者考虑完全禁止中国国有实体收购美国资产。此举可能会阻止中投等买家达成涉及美国的大型交易。

“我觉得我们谁都没想到为中国参与收购美国公司创造便利会成为总统计划的一部分,”美中经济安全审查委员会(United States-China Economic and Security Review Commission)成员迈克尔·R·韦赛尔(Michael R.Wessel)说。“坦白说,这看上去直接违背了他之前一直在宣传的政策和我们的利益。”

这个受国会委托负责监控对华贸易安全影响的委员会,在周三公布了一份逾600页的报告,指责中国实体在美国的活动。

高盛和中投的协议也令部分对中国的收购持怀疑态度的立法者深感震惊。

“商业领袖,比如高盛,应该继续努力把外国的投资和经济扩展引入美国,”北卡罗来纳州共和党众议员罗伯特·皮滕格(Robert Pittenger)说。皮滕格提议立法,扩大负责对外国收购美国资产进行审查的外国在美投资委员会(Committee on Foreign Investment in the United States,简称Cfius)的审查范围。

“我们需要一个强有力的Cfius审查程序,以确保在这个过程中,我们不会在不经意间增强中国的军力,危害到我们自己的国家安全,”皮腾格说。

中投公司长期在美投资。高盛的发言人强调,该基金将重点关注不受Cfius审查的非敏感行业。

这个涉及50亿美元的协议,是特朗普政府上周在特朗普拜访中国国家主席习近平期间宣布的一系列总价值超过2500亿美元的商业协议中的一项。这些协议大部分都缺乏细节,或是已达成的生意。但它们依然表明了中国对很多美国公司的重要性。

“美国私营企业和中国实体上周签署的数十亿美元计的协议,有望给勤劳的美国民众带来成千上万个新的工作机会,”白宫副新闻发言人拉吉夫·沙阿(Raj Shah)说。“每项协议都会接受所有的适用审查。”

调研公司荣鼎咨询(Rhodium Group)的追踪数据显示,自2000年以来,中国企业已宣布的在美投资额高达1365亿美元,其中264亿美元是在2017年前三个季度进入的。大量资金进入了美国中西部和南部的制造业,包括汽车、医疗器械和工业机械。

这让中国资本成了一个复杂的话题。

美国商务部长威尔伯·罗斯(Wilbur Ross)和美国驻华大使特里·布兰斯塔德(Terry Branstad)把高盛与中投公司的这项协议放进上周仓促安排的一些列协议中,在一定程度上是为了显示特朗普政府正在帮助美国企业在中国赚钱。

但据两位贸易顾问称,特朗普政府内部的一些高层顾问对高盛这项协议感到不满,认为它与白宫为了对中国采取更强硬的立场而进行的多项行动相矛盾。因为无权代表白宫发表评论,这两位顾问要求匿名。

就在这些协议公布的一天前,皮腾格和一些议员在华盛顿提议扩大美国对外国投资的审查。

多家公司抗议称,提议的立法限制性太强。在写给皮腾格办公室的一封信中,IBM说,该议案会让授权、共同开发和其他交易成为政府的监管对象,并且Cfius的改变会限制“美国公司在国外做生意的能力,同时有助于外国竞争者占领全球市场”。此前,IBM与中国的合作企业就面临过审查。

高盛在一份声明中说,该基金“的目的是增强商业联系并促进美国公司进入中国市场,还将寻求改善美中贸易关系的平衡”。

美中经济安全审查委员会主席白嘉玲(Carolyn Bartholomew)的怀疑更加强烈。

“我认为重要的是不要忘了,对高盛来说,这都是为了赚钱,”她说。“他们给出的其他任何描述,不过是锦上添花。”

Keith Bradsher自北京报道。

翻译:纽约时报中文网

Goldman Sachs’s China Deal Prompts Questions About Country’s U.S. Investment

WASHINGTON — The Trump administration has pledged to take a tougher stance toward China’s purchases of American know-how in its quest to compete more forcefully with the United States.

So few people expected that, during Mr. Trump’s visit to Beijing last week, a major Wall Street bank would announce it had teamed up with an arm of the Chinese government to make up to $5 billion in deals in the United States.

That deal — between Goldman Sachs and China’s sovereign wealth fund, the China Investment Corporation — illustrates the deep divisions in Washington over China’s trade and investment practices, as well as the complexities of policing the flow of Chinese money into the United States.

On Wednesday, a week after some Trump administration officials praised the deal as one of many that would help American businesses, a congressional commission recommended that lawmakers consider prohibiting entirely the acquisition of United States assets by Chinese state-owned entities — a move that could stop buyers like C.I.C. from reaching major American deals.

“I don’t think any of us expected that easing the way for China to participate in the acquisition of U.S. companies was going to be part of the president’s plans,” said Michael R. Wessel, a member of that group, the U.S.-China Economic and Security Review Commission. “It seems directly counter to the policies he was promoting and, quite frankly, the interests we have.”

The commission, which is charged by Congress with monitoring the security implications of trade with China, released a more than 600-page report Wednesday criticizing activities by Chinese entities in the United States.

The deal has also raised eyebrows among some lawmakers critical of China’s purchases.

“Business leaders, such as Goldman Sachs, should continue to try and bring foreign investment and economic expansion into the country,” said Representative Robert Pittenger, Republican of North Carolina. Mr. Pittenger has proposed legislation that would broaden the scope of the Committee on Foreign Investment in the United States, the agency, known as Cfius, that scrutinizes foreign purchases of American assets.

“We need a strong Cfius review process to ensure that we’re not inadvertently strengthening the Chinese military and jeopardizing our national security in the process,” Mr. Pittenger said.

China Investment Corporation has long invested in the United States, and a Goldman Sachs spokesman emphasized that the fund would focus on nonsensitive industries that are not subject to Cfius review.

The $5 billion deal was among a package of more $250 billion in business pacts that the Trump administration announced last week during Mr. Trump’s visit with President Xi Jinping of China. Most of the deals lacked details or represented already existing business. Still, they showed how important China has become to many companies in the United States.

“The billions of dollars in deals signed between private U.S. businesses and Chinese entities last week carry the promise of thousands of new jobs for hardworking Americans,” said Raj Shah, the deputy press secretary for the White House. “Each of them will go through all applicable review processes.”

Since 2000, Chinese companies have announced $136.5 billion in investments in the United States, with $26.4 billion of that coming in just the first three quarters of 2017, according to tracking by the Rhodium Group, a research firm. Much of that funding has flowed into manufacturing — including of automobiles, medical devices and industrial machinery — in the Midwest and southern United States.

That makes Chinese money a complicated subject.

Wilbur L. Ross, the commerce secretary, and Terry Branstad, the United States ambassador to China, included the Goldman Sachs-C.I.C. deal in the hastily arranged package of China agreements last week in part to show the Trump Administration was helping American businesses make money there.

But some top advisers within the administration were unhappy about the Goldman deal, seeing it as a jarring contradiction to the White House’s efforts to take a tougher stance toward China, according to two trade advisers, who asked to speak anonymously because they were not authorized to comment on the White House’s behalf.

Those deals came just one day after Rep. Pittenger and lawmakers in Washington proposed the expansion of reviews that the United States carries out on foreign investments.

Several companies protested that proposed legislation as too restrictive. In a letter to Mr. Pittenger’s office, IBM — whose China partnerships have faced scrutiny before — said the bill would bring licensing, joint development and other transactions under government regulation, and that a change to Cfius would limit “the ability of American firms to do business abroad while empowering foreign competitors to capture global markets.”

Goldman Sachs said in a statement that the fund “is designed to enhance commercial linkages and promote market access for U.S. firms in China and will seek to improve the balance of the U.S.-China trade relationship.”

Carolyn Bartholomew, the chairwoman of the congressional commission on China, was more skeptical.

“I think it’s important to remember that what this is about is making money for Goldman Sachs,” she said. “Any other way they’re characterizing it is just icing on the cake.”